Intracellular uptake study of radiolabeled anticancer drug and impedimetric detection of its interaction with DNA

Talanta

Volumn 160, Issue , 2016, Pages 157-163

  Top, Mustafa ^a   Er, Ozge ^a   Congur, Gulsah ^a   Erdem, Arzum ^a   Lambrecht, Fatma Yurt ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

131I; Drug DNA interaction; Impedimetric Detection; Small cell lung cancer; Topotecan

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; CELLS; CHARGE TRANSFER; CHROMATOGRAPHY; DISEASES; DNA; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTROPHORESIS; QUALITY CONTROL; RESPIRATORY SYSTEM;

DRUG-DNA INTERACTIONS; IMPEDIMETRIC DETECTIONS; SMALL CELL LUNG CANCERS; TOPOTECAN; ^131I;

DRUG INTERACTIONS;

ANTINEOPLASTIC AGENT; DNA; RADIOACTIVE IODINE; TOPOTECAN;

A-549 CELL LINE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

A549 CELLS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; DIELECTRIC SPECTROSCOPY; DNA; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; TOPOTECAN;

EID: 84978766042     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2016.06.058     Document Type: Article

References (40)

1. [1] Baskar, R., Lee, K.A., Yeo, R., Yeoh, K.-W., Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9 (2012), 193–199.
2. [2] Horn, L., Pao, W., Johnson, D.H., Chapter 89. Longo, D.L., Kasper, D.L., Jameson, J.L., Fauci, A.S., Hauser, S.L., Loscalzo, J., (eds.) Harrison's Principles of Internal Medicine, 18th ed., 2012, McGraw-Hill Part 7, Section 1.
3. [3] W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris, Pathology and genetics of tumours of the lung, pleura, thymus and heart, World Health Organization Classification of Tumours, 2010. (Online) 〈http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/〉 (accessed 8.11.15).
4. [4] Staker, B.L., Hjerrild, K., Feese, M.D., Behnke, C.A. Jr., Burgin, A.B., Stewart, L., The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. USA 99 (2002), 15387–15392.
5. [5] Devriese, L.A., Witteveen, P.O., Mergui-Roelvink, M., Smith, D.A., Lewis, L.D., Mendelson, D.S., Bang, Y.-J., Chung, H.C., Dar, M.M., Huitema, A.D.R., Beijnen, J.H., Voest, E.E., Schellens, J.H.M., Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function. Br. J. Clin. Pharmacol. 80 (2015), 253–266.
6. [6] Enomoto, Y., Inui, N., Imokawa, S., Karayama, M., Hasegawa, H., Ozawa, Y., Matsui, T., Yokomura, K., Suda, T., Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease. Cancer Chemother. Pharmacol. 76 (2015), 499–505.
7. [7] Congur, G., Erdem, A., Mese, F., Electrochemical investigation of the interaction between topotecan and DNA at disposable graphite electrodes. Bioelectrochemistry 102 (2014), 21–28.
8. [8] Ak, G., Yurt Lambrecht, F., Hamarat Sanlier, S., Radiolabeling of folate targeted multifunctional conjugate with technetium-99m and biodistribution studies in rats. J. Drug Target. 20 (2012), 509–514.
9. [9] Lambrecht, F.Y., Durkan, K., Unak, P., Preparation, quality control and stability of 99mtc-cefuroxime axetil. J. Radioanal. Nucl. Chem. 275 (2008), 161–164.
10. 131I-protohypericin as a necrosis avid compound. J. Drug Target. 6 (2015), 1–10.
11. 11C-labeled topotecan using small-animal positron emission tomography. Nucl. Med. Biol. 38:5 (2011), 707–714.
12. 131iodine. J. Nucl. Med. 43 (2002), 856–861.
13. [13] Biersack, H.J., Freeman, L.M., Clinical Nuclear Medicine, 2007, Springer Verlag, Berlin Heilderberg, 542–548.
14. −131 for the therapy of graves' disease. Malays. J. Med. Sci. 16 (2009), 25–33.
15. 131I] iazgp via nucleophilic substitutionand its biological evaluation as a hypoxia marker—is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?. Nucl. Med. Biol. 36 (2009), 477–487.
16. [16] Palecek, E., Oscillographic polarography of highly polymerized deoxyribonucleic acid. Nature 188 (1960), 656–657.
17. [17] Erdem, A., Ozsoz, M., Electrochemical DNA biosensors based on DNA-drug interactions. Electroanalysis 14 (2002), 965–974.
18. [18] Yunus, G., Srivastava, S., Kuddus, M., Gupta, V.D., Drug-DNA interaction: a theoretical study on the binding of thionine with DNAs of varying base composition. Curr. Appl. Phys. 13 (2013), 322–326.
19. [19] Marin, D., Perez, P., Teijeiro, C., Palecek, E., Interactions of surface-confined DNA with acid-activated mitomycin, C. Biophys. Chem. 75 (1998), 87–95.
20. [20] Berti, F., Lozzi, L., Palchetti, I., Santucci, S., Marrazza, G., Aligned carbon nanotube thin films for DNA electrochemical sensing. Electrochim. Acta 54 (2009), 5035–5041.
21. [21] Laschi, S., Castro, R.M., Fernandez, E.G., Palchetti, I., Reymond, F., Rossier, J.S., Marrazza, G., A new gravity-driven microfluidic-based electrochemical assay coupled to magnetic beads for nucleic acid detection. Electrophoresis 31 (2010), 3727–3736.
22. [22] Guo, X.X., Song, Z.J., Sun, J.J., Song, J.F., Interaction of calf thymus dsDNA with anti-tumor drug tamoxifen studied by zero current potentiometry. Biosens. Bioelectron. 26 (2011), 4001–4005.
23. [23] Oliviera, S.C.B., Chiorcea-Pagium, A.M., Ribeiro, S.M., Melo, A.T.P., Vivan, M., Oliveira-Brett, A.M., In situ electrochemical and AFM study of thalidomide-DNA interaction. Bioelectrochemistry 76 (2009), 201–207.
24. [24] Li, C.Z., Liu, Y., Luong, J.H.T., Impedance sensing of DNA binding drugs using gold substrates modified with gold nanoparticles. Anal. Chem. 77 (2005), 478–485.
25. [25] Gherghi, I.C., Girousi, S.T., Voulgaropoulos, A.N., Tzimou-Tsitouridou, R., Study of interactions between actinomycin D and DNA on carbon paste electrode (CPE) and on the hanging mercury drop (HMDE) surface. J. Pharm. Biomed. Anal. 31 (2003), 1065–1078.
26. [26] Jelen, F., Erdem, A., Palecek, E., Cyclic voltammetry of echinomycin and its interacion with double-stranded and single-stranded DNA adsorbed at the electrode. Bioelectrochemistry 55 (2002), 165–167.
27. [27] Feng, Q., Li, N.Q., Jiang, Y.Y., Enhanced sensitivity for deoxyribonucleic acid electrochemical impedance sensor: gold nanoparticle/polyaniline nanotube membranes. Anal. Chim. Acta 344 (1997), 97–104.
28. [28] Diculescu, V.C., Oliviera-Brett, A.M., In situ electrochemical evaluation of dsDNA interaction with the anticancer drug danusertib nitrenium radical product using the DNA-electrochemical biosensor. Bioelectrochemistry 107 (2016), 50–57.
29. [29] Asghary, M., Raoof, J.B., Ojani, R., Hamidi-Asl, E., A genosensor based on CPE for study the interaction between ketamine as an anesthesia drug with DNA. Int. J. Biol. Macromol. 80 (2015), 512–519.
30. [30] Temerk, Y., Ibrahim, M., Ibrahim, H., Kotb, M., Interactions of an anticancer drug formestane with single and double stranded DNA at physiological conditions. Photochem. Photobiol. B 149 (2015), 27–36.
31. [31] Nunn, C.M., Meervelt, L.V., Zhang, S., Moore, M.H., Kennard, O., The cyrstal structures of d(TGTACA) and d(TGATCA) (complexed with daunomycin). J. Mol. Biol. 222 (1991), 167–177.
32. [32] Erdem, A., Muti, M., Papakonstantinou, P., Canavar, E., Karadeniz, H., Congur, G., Sharma, S., Graphene oxide integrated sensor for electrochemical monitoring of mitomycin C–DNA interaction. Analyst 137 (2012), 2129–2135.
33. [33] Eksin, E., Muti, M., Erdem, A., Chitosan/ionic liquid composite electrode for electrochemical monitoring of the surface-confined interaction between mitomycin C and DNA. Electroanalysis 25 (2013), 2321–2329.
34. [34] Erdem, A., Congur, G., Impedimetric detection of in situ interaction between anti-cancer drug bleomycin and DNA. Int. J. Biol. Macromol. 61 (2013), 295–301.
35. [35] Teijeiro, C., Perez, P., Marin, D., Paleček, E., Cyclic voltammetry of mitomycin C and DNA. Bioelectrochem. Bioenerg. 38 (1995), 77–83.
36. [36] Kalanur, S.S., Katrahalli, U., Seetharamappa, J., Electrochemical studies and spectroscopic investigations on the interaction of an anticancer drug with DNA and their analytical applications. J. Electroanal. Chem. 636 (1999), 93–100.
37. [37] Marrazza, G., Chiti, G., Mascini, M., Anichini, M., Detection of human apolipoprotein E genotypes by DNA electrochemical biosensor coupled with PCR. Clin. Chem. 46 (2000), 31–37.
38. [38] Radi, A.E., Eissa, A., Nassef, H.M., Voltammetric and spectroscopic studies on the binding of the antitumor drug dacarbazine with DNA. J. Electroanal. Chem. 717 (2014), 24–28.
39. [39] DeLand, F.H., Shih, W.J., The status of SPECT in tumor diagnosis. J. Nucl. Med. 25 (1984), 1375–1379.
40. [40] Eksin, E., Congur, G., Mese, F., Erdem, A., Electrochemical monitoring of surface confined interaction between 6-thioguanine and DNA by using single-use graphite electrode. J. Electroanal. Chem. 733 (2014), 33–38.